This is a discussion on ASCO Updates Guidelines for Hormone Therapy for Breast Cancer within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The new guidelines are evidence-based, so there is greater certainty behind the recommendation to use aromatase inhibitors in postmenopausal ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
The new guidelines are evidence-based, so there is greater certainty behind the recommendation to use aromatase inhibitors in postmenopausal women.
Medscape Medical News More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| North American Menopause Society Issues Guidelines on Hormone Therapy | industry_news | Other Clinical Pharmacy News | 0 | 02-19-2010 02:22 AM |
| Hormone Therapy Increases Risk for Ovarian Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-15-2009 05:27 PM |
| ASCO 2009: Avoid SSRIs in Breast Cancer Patients on Tamoxifen | industry_news | Other Clinical Pharmacy News | 0 | 06-02-2009 03:16 PM |
| ASCO Updates Guideline on Chemotherapy and Radiation Protectants | industry_news | Other Clinical Pharmacy News | 0 | 11-20-2008 06:08 PM |
| NAMS Updates Guidelines on Postmenopausal Hormone Therapy | industry_news | Other Clinical Pharmacy News | 0 | 07-03-2008 10:13 AM |